CLRB•benzinga•
Cellectar Biosciences Says Its Cash Balance Of $23.3M As Of December 31, 2024, Is Adequate To Fund Its Basic Budgeted Operations Into The Fourth Quarter Of 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 13, 2025 by benzinga